Frequency of iron deficiency anaemia in chronic kidney disease patients not on dialysis

被引:0
|
作者
Kamil, Faryal [1 ]
Dhrolia, Murtaza [1 ]
Hamid, Aamna [1 ]
Qureshi, Ruqaya [1 ]
Nasir, Kiran [1 ]
Ahmad, Aasim [1 ]
机构
[1] Kidney Ctr Post Grad Training Inst, Dept Nephrol, Karachi, Pakistan
关键词
  Iron deficiency; Anaemia; Chronic kidney disease; NATIONAL-HEALTH; UNITED-STATES; PREVALENCE; MANAGEMENT; BURDEN; ADULTS; RISK;
D O I
10.47391/JPMA.4507
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the frequency of iron deficiency anaemia in non-dialysis chronic kidney disease patients. Method: The observational, cross-sectional study was conducted at the Department of Nephrology, The Kidney Centre Post-Graduate Training Institute, Karachi, from April 27 to October 26, 2018, and comprised adult patients of either gender diagnosed with anaemia and estimated glomerular filtration rate <90ml/min. Patient with transferrin saturation <20% were labelled as having iron deficiency anaemia. Data was analysed using SPSS 21. Results: Of the 366 participants, 185(50.5%) were males and 181(49.5%) were females. The overall mean age was 54.47 +/- 14.93 years. The most prevalent comorbid was hypertension 263(71.9%), followed by diabetes mellitus 187(51.1%) and cardiovascular disease 54(14.8%). Besides, 192(52.5%) patients had CKD stage 5 followed by 115(31.4%) and 54(14.8%) with CKD stages 4 and 3, respectively. The mean haemoglobin was 9.17 +/- 1.57g/dL. Iron deficiency was found in 285(77.9%) patients. Conclusion: Iron deficiency anaemia was found to be highly prevalent and should be screened routinely and managed appropriately.
引用
收藏
页码:1396 / 1400
页数:5
相关论文
共 50 条
  • [31] Ferumoxytol: A guide to its use in iron deficiency anaemia in adults with chronic kidney disease in the EU
    Scott L.J.
    Lyseng-Williamson K.A.
    McCormack P.L.
    Drugs & Therapy Perspectives, 2013, 29 (8) : 223 - 227
  • [32] Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease
    Roger, Simon D.
    CLINICAL KIDNEY JOURNAL, 2017, 10 : 9 - 15
  • [33] Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa
    Nalado, Aishatu M.
    Olorunfemi, Gbenga
    Dix-Peek, Therese
    Dickens, Caroline
    Khambule, Lungile
    Snyman, Tracy
    Paget, Graham
    Mahlangu, Johnny
    Duarte, Raquel
    George, Jaya
    Naicker, Saraladevi
    BMC NEPHROLOGY, 2020, 21 (01)
  • [34] Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa
    Aishatu M. Nalado
    Gbenga Olorunfemi
    Therese Dix-Peek
    Caroline Dickens
    Lungile Khambule
    Tracy Snyman
    Graham Paget
    Johnny Mahlangu
    Raquel Duarte
    Jaya George
    Saraladevi Naicker
    BMC Nephrology, 21
  • [35] Deficiency in the Screening Process of Fabry Disease: Analysis of Chronic Kidney Patients Not on Dialysis
    Battaglia, Yuri
    Fiorini, Fulvio
    Azzini, Cristiano
    Esposito, Pasquale
    De Vito, Alessandro
    Granata, Antonio
    Storari, Alda
    Mignani, Renzo
    FRONTIERS IN MEDICINE, 2021, 8
  • [36] Vitamin D deficiency in chronic kidney disease and dialysis patients of Kathmandu valley
    Gupta, R. K.
    CLINICA CHIMICA ACTA, 2022, 530 : S235 - S236
  • [37] ON PATHOGENESIS OF HEPATOSPLENOMEGALY IN CHRONIC IRON DEFICIENCY ANAEMIA - A STUDY IN 5 PATIENTS WITH A SYNDROME OF CHRONIC IRON DEFICIENCY ANAEMIA HEPATOSPLENOMEGALY HYPOGONADISM AND DWARFISM
    AKSOY, M
    ERDEM, S
    BASERER, G
    ACTA HEPATO-SPLENOLOGICA, 1968, 15 (04): : 241 - &
  • [38] Iron Deficiency Anemia in Chronic Kidney Disease
    Gaiter-Gvili, Anat
    Schechter, Amir
    Rozen-Zvi, Benaya
    ACTA HAEMATOLOGICA, 2019, 142 (01) : 44 - 50
  • [39] Iron and Clinical Outcomes in Dialysis and Non-Dialysis-Dependent Chronic Kidney Disease Patients
    Kovesdy, Csaba P.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2009, 16 (02) : 109 - 116
  • [40] Ferumoxytol for treatment of iron deficiency anemia in patients with chronic kidney disease
    Coyne, Daniel W.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (15) : 2563 - 2568